A Study To Compare Effects Of GSK189075 In Combination With Either Furosemide Or Hydrochlorothiazide

NCT00671424 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus
Diabetes Mellitus, Type 2

Interventions

DRUG: Hydrochlorothiazide (HCTZ)
DRUG: Remogliflozin etabonate (GSK189075)
DRUG: Furosemide

Sponsor

GlaxoSmithKline